- US12577226utility2026Compounds for Treating Huntington's Disease0 cites
- US12509434utility2025Optically Resolved Trolox Intermediate and Method for Producing Same0 cites
- US12458629utility2025Method for Treating Nonsense Mutation Mediated Duchenne Muscular Dystrophy in Pediatric Patients0 cites
- US12398140utility2025Substituted Pyrrolo [2,3-d]pyrimidines for Treating Familial Dysautonomia0 cites
- US12384789utility2025Compounds for Treating Huntington's Disease0 cites
- US12384797utility2025Thioeno[3,2-b] Pyridin-7-amine Compounds for Treating Familial Dysautonomia0 cites
- US12281083utility20252-substituted Amino-naphth (1,2-d) Imidazol-5-one Compounds of Pharmaceutically Acceptable Salts Thereof0 cites
- US12139499utility2024Heteroaryl Compounds for Treating Huntington's Disease0 cites
- US12103926utility2024Compounds for Treating Huntington's Disease0 cites
- US12023335utility2024Method for Treating Pancreatic Cancer0 cites
- US11938101utility2024Polymorphic Forms of (r)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide0 cites
- US11858941utility2024Heterocyclic and Heteroaryl Compounds for Treating Huntington's Disease0 cites
- US11840497utility20234-(p-quinonyl)-2-hydroxybutanamide Derivatives for Treatment of Mitochondrial Diseases0 cites
- US11827646utility2023Compounds for Treating Spinal Muscular Atrophy0 cites
- US11786486utility2023Pharmaceutical Compositions Comprising 2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione0 cites
- US11780839utility2023Compounds for Treating Huntington's Disease0 cites
- US11702646utility2023Methods for Modulating RNA Splicing0 cites
- US11685746utility2023Heteroaryl Compounds for Treating Huntington's Disease0 cites
Page 1 of 2Next →